Talkspace, Inc. has 14 Schedule 13D or 13G filings on record since 2025-07-29. 2 holders' latest filing reports 5% or more of common stock, $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BlackRock, Inc. | 6.6% | 11,117,221 | SCHEDULE 13G/A, 2026-07-30 | 2026-06-30 |
| Barclays PLC | 6.11% | 2,527,393 | SCHEDULE 13G, 2026-05-14 | 2026-03-31 |
| MAK Capital Fund LP | 4.2% | 6,929,273 | SCHEDULE 13G/A, 2026-03-12 | 2026-03-09 |
| Balyasny Asset Management L.P. | 4.09% | 6,857,833 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
| Hudson Executive Capital LP | 0% | 0 | SCHEDULE 13D/A, 2026-08-17 | 2026-08-17 |
| Qumra Capital Ii, L.P. | 0% | 0 | SCHEDULE 13D/A, 2026-08-17 | 2026-08-17 |
| Norwest Venture Partners XIII, LP | 0% | 0 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
Purpose of Transaction (Item 4)
Hudson Executive Capital LP
Item 4 of the Existing Schedule 13D is hereby amended and supplemented by adding the following: On August 17, 2026, the merger (the "Merger") contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated March 9, 2026, by and among the Issuer, Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), was consummated. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, and the Issuer continued as the surviving corporation as an indirect wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each outstanding share of Common Stock (other than shares of Company Common Stock to be canceled pursuant to the Merger Agreement and shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law) was automatically converted into the right to receive $5.25 in cash, without interest (the "Merger Consideration"). In addition, as of the Effective Time, each stock option granted under the Issuer's equity incentive plans (a "Stock Option") that was vested as of the Effective Time (each, a "Vested Stock Option") was cancelled and converted into the right to receive an amount in cash equal to the excess, if any, of (i) the Merger Consideration over (ii) the per share exercise price of such Vested Stock Option. Each restricted stock …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-17; the filing has the rest
Qumra Capital Ii, L.P.
Item 4 of the Existing Schedule 13D is hereby amended and supplemented by adding the following: On August 17, 2026, the merger (the "Merger") contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated March 9, 2026, by and among the Issuer, Universal Health Services, Inc., a Delaware corporation ("Parent"), and UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub") was consummated. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, and the Issuer continued as the surviving corporation as an indirect wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each outstanding share of Common Stock (other than shares of Company Common Stock to be canceled pursuant to the Merger Agreement and shares with respect to which appraisal rights were properly exercised and not withdrawn under Delaware law) was automatically converted into the right to receive $5.25 in cash, without interest (the "Merger Consideration"). In addition, as of the Effective Time, each stock option granted under the Issuer's equity incentive plans (a "Stock Option") that was vested as of the Effective Time (each, a "Vested Stock Option") was cancelled and converted into the right to receive an amount in cash equal to the excess, if any, of (i) the Merger Consideration over (ii) the per share exercise price of such Vested Stock Option. Each restricted stock …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-17; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-29 | The Vanguard Group | 5.36% | SCHEDULE 13G |
| 2025-10-17 | BlackRock, Inc. | 5.4% | SCHEDULE 13G |
| 2026-03-02 | MAK Capital Fund LP | 5.2% | SCHEDULE 13G |
| 2026-03-10 | Hudson Executive Capital LP | 14.9% | SCHEDULE 13D/A |
| 2026-03-12 | MAK Capital Fund LP | 4.2% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-03-30 | Qumra Capital Ii, L.P. | 5.4% | SCHEDULE 13D/A |
| 2026-05-14 | Barclays PLC | 6.11% | SCHEDULE 13G |
| 2026-05-15 | Balyasny Asset Management L.P. | 5.31% | SCHEDULE 13G |
| 2026-05-15 | Norwest Venture Partners XIII, LP | 0% | SCHEDULE 13G/A |
| 2026-07-30 | BlackRock, Inc. | 6.6% | SCHEDULE 13G/A |
| 2026-08-14 | Balyasny Asset Management L.P. | 4.09% | SCHEDULE 13G/A |
| 2026-08-17 | Hudson Executive Capital LP | 0% | SCHEDULE 13D/A |
| 2026-08-17 | Qumra Capital Ii, L.P. | 0% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Talkspace, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
